Literature DB >> 21132538

Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancer.

Anna Isinger-Ekstrand1, Christina Therkildsen, Inge Bernstein, Mef Nilbert.   

Abstract

The Wnt signaling pathway is frequently deranged in colorectal cancer and is a key target for future preventive and therapeutic approaches. Colorectal cancers associated with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome are characterized by wide-spread microsatellite instability, but show few gross genomic alterations. We characterized expression of the Wnt signaling pathway markers β-catenin, E-cadherin, TCF-4, and PTEN using immunohistochemical staining in colorectal cancers from individuals with HNPCC. Reduced membranous staining for β-catenin was found in 64% and for E-cadherin in 80% with strong correlation between these markers (P = 0.001). Nuclear β-catenin staining was detected in 19% of the tumors. Overexpression of TCF-4, which is activated by β-catenin, was found in 89% and downregulation of PTEN, which suppresses nuclear accumulation of β-catenin, was present in 54% of the tumors. In summary, altered expression of target molecules in the Wnt signaling pathway was demonstrated in the vast majority of the HNPCC-associated tumors, which support deranged Wnt-signaling as a central tumorigenic mechanism also in MMR defective colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21132538     DOI: 10.1007/s10689-010-9406-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

Review 1.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.

Authors:  J R Jass
Journal:  Histopathology       Date:  2007-01       Impact factor: 5.087

2.  Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.

Authors:  Yosuke Shimizu; Satoshi Ikeda; Masahiko Fujimori; Shinya Kodama; Masahiro Nakahara; Masazumi Okajima; Toshimasa Asahara
Journal:  Genes Chromosomes Cancer       Date:  2002-01       Impact factor: 5.006

3.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

4.  The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.

Authors:  A Duval; S Rolland; E Tubacher; H Bui; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

5.  Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.

Authors:  R Gafà; I Maestri; M Matteuzzi; A Santini; S Ferretti; L Cavazzini; G Lanza
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

6.  Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability.

Authors:  A Duval; J Gayet; X P Zhou; B Iacopetta; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

7.  Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.

Authors:  V Johnson; E Volikos; S E Halford; E T Eftekhar Sadat; S Popat; I Talbot; K Truninger; J Martin; J Jass; R Houlston; W Atkin; I P M Tomlinson; A R J Silver
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

8.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 9.  The colorectal adenoma-carcinoma sequence.

Authors:  A Leslie; F A Carey; N R Pratt; R J C Steele
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

10.  Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.

Authors:  S Persad; A A Troussard; T R McPhee; D J Mulholland; S Dedhar
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

View more
  4 in total

Review 1.  Animal models of colorectal cancer.

Authors:  Robert L Johnson; James C Fleet
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 2.  Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer.

Authors:  James C Fleet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

3.  Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.

Authors:  Christina Therkildsen; Anna Isinger-Ekstrand; Steen Ladelund; Anja Nissen; Eva Rambech; Inge Bernstein; Mef Nilbert
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

4.  Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.

Authors:  Stefan Haraldsson; Louise Klarskov; Mef Nilbert; Inge Bernstein; Jesper Bonde; Susanne Holck
Journal:  BMC Clin Pathol       Date:  2017-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.